Fredun Pharma Allots 44,000 Equity Shares on Warrant Conversion

Fredun Pharmaceuticals Ltd has allotted 44,000 equity shares of face value Rs. 10 each to three non-promoter allottees upon conversion of warrants. The conversion follows the payment of the balance consideration by warrant holders and is pursuant to shareholder approval from an EGM held on October 22, 2025. The warrants were initially allotted on December 29, 2025. After a 1:2 bonus issue, 14,667 warrants were converted into 44,000 equity shares. The issue price per warrant was Rs. 1,250, with 25% payable upfront. The newly allotted shares will rank pari passu with existing equity shares.